BridgeMD
Compares treatment options for Plantar Fasciitis of Both Feet
Official title Video-Based Versus Physician-Led Exercise Training for Plantar Fasciitis
ClinicalTrials.gov ID: NCT07628218
What this study is testing
- What it's testing
- This prospective, single-center, two-arm, parallel-group randomized non-inferiority trial will compare physician-led face-to-face exercise instruction with standardized video-based exercise instruction in adults with plantar fasciitis. Participants will be randomized in a 1:1 ratio to receive either face-to-face exercise training by an orthopedic physician or access to a standardized exercise video via QR code/web link.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 70
You may be able to join if
- Adults aged 18 to 70 years
- Clinical diagnosis of plantar fasciitis
- Plantar heel pain lasting for at least 3 months
- Heel pain that is most prominent with the first steps in the morning or after rest
- Tenderness on palpation of the medial calcaneal tubercle
You likely can't join if
- Previous foot or ankle surgery on the affected side
- History of foot fracture, foot tumor, advanced neuropathy, Charcot arthropathy, or tarsal tunnel syndrome
- Corticosteroid injection, extracorporeal shock wave therapy, platelet-rich plasma injection, or other treatment treatment for plantar fasciitis...
- Inflammatory arthritis or systemic rheumatologic disease affecting the foot
- Severe knee or hip osteoarthritis limiting exercise performance
- Severe cognitive impairment preventing participation or completion of questionnaires
See the full eligibility criteria
- Adults aged 18 to 70 years
- Clinical diagnosis of plantar fasciitis
- Plantar heel pain lasting for at least 3 months
- Heel pain that is most prominent with the first steps in the morning or after rest
- Tenderness on palpation of the medial calcaneal tubercle
- Baseline heel pain score of 4 or higher on a 0-10 numerical rating scale
- Functional capacity to perform the prescribed exercises
- Access to a smartphone, tablet, or computer to view the exercise video
- Ability to provide written informed consent
- Previous foot or ankle surgery on the affected side
- History of foot fracture, foot tumor, advanced neuropathy, Charcot arthropathy, or tarsal tunnel syndrome
- Corticosteroid injection, extracorporeal shock wave therapy, platelet-rich plasma injection, or other treatment treatment for plantar fasciitis within the last 6 months
- Inflammatory arthritis or systemic rheumatologic disease affecting the foot
- Severe knee or hip osteoarthritis limiting exercise performance
- Severe cognitive impairment preventing participation or completion of questionnaires
- Pregnancy
- Inability or unwillingness to comply with the study protocol
The study team makes the final eligibility decision.
Where it's taking place
- Balıkesir, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 70 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Balıkesir, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.